This prospective , randomized , controlled clinical study investigates the differences in pain , quality of life , and cost of care in the treatment of tibia plateau fractures-associated bone defects using either autologous bone grafting or bioresorbable hydroxyapatite/calcium sulphate cement ( CERAMENT | BONE VOID FILLER ( CBVF ) ) .